Imipenem resistance  is an emerging threat in nosocomial infections caused by Pseudomonas aeruginosa. Imipenem resistant Pseudomonas aeruginosa (IR-PA) with a increased mortality and morbidity worsen the situation by virtue of their multi-drug resistance and thus limit therapeutic options. Very limited data available on IR-PA nosocomial  infections and associated predisposing risk factors necessitated the present study. Of the 523 patients presenting with P. aeruginosa, 110 isolates from nosocomial infections (as per CDC definitions) were analyzed by Kirby-Bauer’s disc diffusion method of antimicrobial susceptibility testing for the detection of IR-PA. Predisposing risk factors were analyzed by student “t” test, and “z” test for proportions, using SPSS for windows, version 13.0. Incidence of  Imipenem resistant  Pseudomonas aeruginosa  infections was 21.82% with eight distinct antibiogram types circulating in the hospital. Overall mortality in P. aeruginosa infections  was 13.63% (15/110). Increased mortality was observed in IR-PA than in IS-PA (33.3% Vs 8.14% P value=0.01 S) with a mean duration of stay in ICU till death of 3.16±0.98 days indicating the severity of the infections. Majority of deaths among IR-PA infections were due to VAP as an underlying disease. Previous Imipenem therapy was significantly associated with IR-PA infections (P value <0.001 HS) resulting in emergence and/or acquisition of IR-PA. Other predisposing risk factors were significantly associated with IR-PA infections. IR-PA infections results in significantly higher mortality than IS-PA. VAP is the underlying disease in majority of  deaths due to IR-PA infections. Attributable mortality in IR-PA infections, is partially mediated by Imipenem resistance, severity of underlying disease, predisposing risk factors, Multidrug resistance and Pan drug resistance, making IR-PA isolate, a successful and difficult to treat pathogen. Patients in whom Imipenem is selected as antipseudomonal antibiotic, the potential for emergence of IR-PA strains should be anticipated, and in appropriate circumstance, routine culture and sensitivity should be performed to detect the emergence of IR-PA strains. These findings can be generalized to other tertiary care hospitals with similar conditions.